NLRP3 and neoplasm: Analysis of tumour growth revealed that tumours co-injected with Nlrp3−/− NMFs were significantly smaller than tumours injected with WT fibroblasts (Fig. 4b, c), suggesting that expression of NLRP3 in CAFs supports tumour growth.